Arieli Group and Shaare Zedek Medical Center Launch SHAAR, New Jerusalem Innovation Hub

JERUSALEM and NEW YORK, March 5, 2025 /PRNewswire/ -- Arieli Group and the Jerusalem's Shaare Zedek Medical Center (SZMC) announce the official opening of the SZMC-Arieli Healthcare Innovation Hub (SHAAR), a new physical innovation and co-working space within the medical center, marking a significant milestone in the advancement of the city's healthtech ecosystem. The partnership, established in 2023, is led by Shaare Zedek Scientific-Madait (SZS), the research and innovation arm of SZMC, and Arieli Group.

SHAAR combines SZMC's medical expertise and world-class facilities with Arieli Group's investment experience and track record of fostering innovation and growth platforms. The Hub builds a gateway between innovation and capital, creating an environment where cutting-edge medical research, pioneering projects, and forward-thinking startups can thrive.

Since its launch, SHAAR has been active in facilitating advanced innovation programs, providing startups with access to funding, business development opportunities, and clinical development advancement. To date, 19 companies have participated in SHAAR's innovation programs. Since the completion of the first cohort in April 2024, graduating companies have achieved significant milestones. One company secured FDA approval for its device, and six companies have initiated clinical trials, two of which are being conducted at Shaare Zedek Medical Center. Additionally, six companies have successfully raised follow-on funding, and three graduates have received patent approvals.

Prof. Dan Turner, Vice President for Research, Development and Innovation at Shaare Zedek Medical Center, said: "Innovation and progress are the result of huge collaborative efforts, perseverance, and endless hours. Yet still only 10% of startup companies in the health industry succeed. We firmly believe that the likelihood of success can be much improved with a backwind of a professional, focused, and coordinated system like the SHAAR Hub. We harness the know-how, team and infrastructure of Shaare Zedek to advance ideas and improve patient care. This is our mission and vision."

Evan Renov, Co-founder and Managing Partner at Arieli Group, said: "At Arieli Group, we're committed to bridging the gap between pioneering healthcare solutions and the capital that can bring these technologies to life. At SHAAR, we have created a physical space for innovative ideas and startups alongside a powerful ecosystem that bolsters companies' success with the resources and expertise needed to scale. With the official opening of SHAAR, we are excited to expand our platform for working alongside the global investment and healthcare community to further drive innovation and success in the healthcare sector."

The ribbon-cutting ceremony took place in the attendance of SZMC Director General, Prof. Ofer Merin; SZMC Vice President for Research, Development and Innovation, Prof. Dan Turner; CEO of Shaare Zedek Scientific, Dr. Renana Ofan; and Evan Renov, Eric Bentov, Lisya Bahar Manoah, and Or Haviv, partners at Arieli Group. Additional guests included members of the SZMC Board of Directors, representatives from the Jerusalem Municipality, the Jerusalem Development Authority and the Israel Innovation Authority, and international investors and members of the healthcare community.

About SHAAR:
Founded by Shaare Zedek Medical Center and Arieli Group, SHAAR's mission is to build a gateway between innovation and capital, creating an environment where cutting-edge medical research, pioneering projects, and forward-thinking startups can thrive through strategic financial and professional support. The hub facilitates advanced innovation programs and access to investment and funding opportunities, providing startups and medical projects with the resources needed to turn visionary healthcare ideas into impactful solutions. SHAAR, located within the Shaare Zedek Medical Center, combines SZMC's medical expertise and world-class facilities with Arieli's investment experience and track record of fostering innovation and growth platforms. For more information, please visit www.shaarhealth.com.

About Shaare Zedek Medical Center:
Shaare Zedek Medical Center (SZMC) is the largest multi-disciplinary medical center in Jerusalem, treating nearly 1,000,000 patients annually in 30 inpatient departments and 70 ambulatory care units. With a constant commitment to improve and provide our patients with the best possible care, the 1000-bed facility and staff of over 4,500 people is dedicated to combining compassionate medical care with a constant attention to groundbreaking scientific research and technological development to benefit the advancement of medicine in Israel and around the world. For more information, please visit www.szmc.org.il/en.

About Shaare Zedek Scientific:
Shaare Zedek Scientific Ltd. (SZS) is the research and innovation arm of Shaare Zedek Medical Center, Jerusalem's fastest-growing major medical center. Our goal is to act as an innovation bridge between leading companies in the fields of medical research and our hospital. Madait's strength is in converting initial research initiatives into novel medical treatments by leveraging our hospital's abilities, facilities, patients, and team expertise for the advancement of medical science. Our daily mission is to ensure that Shaare Zedek's growing successes in research and clinical care also benefits the global healthcare community. For more information, please visit www.madait.co.il.

About Arieli Group:
Arieli Group is a global investment firm committed to creating enduring prosperity. We partner with visionary entrepreneurs who are transforming bold ideas into groundbreaking technologies that shape the future. With a forward-thinking approach, Arieli invests in early and growth-stage companies across industries including cybersecurity, defense, deep tech, energy, healthcare, fintech, and agritech. Rooted in a third-generation family office, Arieli is dedicated to building the next generation of technologies and driving them forward. For more information, visit www.arieli-group.com.

Contact:

Arieli Group

Nataf Dgani, Head of Marketing 
+972-54-757-3384; [email protected]

Nurit Kantarovitz, VP Strategic Partnerships 
+972-54-441-6834; [email protected] 

SOURCE Arieli Group; Shaare Zedek Medical Center